Roger Strode, a partner with the global law firm Foley and Lardner, explains why private equity investors have grown more and more interested in cardiology in recent years.
Consider, for instance, the sudden rise of multiple cardiology-focused physician practice management platforms in the United States. Cardiovascular Associates of America, operated by Webster Equity Partners, US Heart and Vascular, operated by Ares Management, and Partners First Cardiology, operated by Varsity Healthcare Partners, have all started gaining significant momentum by scooping up smaller cardiology practices and increasing their market share.
Why are private equity investors so interested in cardiology right now? What does this influx of investments mean for other practices?
Strode has represented the “buy-side” in some of those deals, helping firms make the smartest investments possible, and he has represented the “sell-side” in other deals, helping ensure smaller physician practices get the benefits of new ownership, while still maintaining their own identities. Read more.
